IQVIA Holdings Inc.

IQV Healthcare · Diagnostics & Research
Delayed 15 min
Last close
$193.28
Jun 29, 2026
52-week range
$154.50 — $247.05
-22% from high
Market cap
32.3B
Diluted basis
Dividend yield
No dividend declared
P/E
24.0
Trailing
Filing.fyi verdict · Jun 29, 2026

Fairly valued.

Fairly Valued (Neutral) — Filing.fyi's reading derived from the latest 10-K and forensic scores.

Neutral
RED DEEP / 100
Composite Health
AI synthesis · grounded in this ticker's SEC filings · drag to highlight, releases the composer

What the filing actually says.

AI · wry-editorial preset

IQVIA Holdings Inc.’s 2026 10-Q opens its Management’s Discussion and Analysis (MD&A) with a “Cautionary Statement for Forward-Looking Information,” which are statements about future events or financial performance that are inherently subject to various risks and uncertainties. This immediate directive instructs readers to consult the company’s 2025 Form 10-K for a comprehensive understanding of its financial condition and results of operations. Such an approach suggests that the current quarterly report serves primarily as an update, rather than a standalone exposition of the company’s full financial narrative. The initial focus on procedural cross-referencing, rather than immediate, specific financial details, establishes a particular tone for the filing.

The quantitative forensic analysis of this filing is, by necessity, incomplete. Beneish’s 1999 eight-ratio earnings-manipulation detector (M-Score), Altman’s 1968 bankruptcy-distress index (Z″), and Piotroski’s 2000 nine-point fundamental strength scan (F-Score) are all “not available” for this report. Similarly, the Fog Index — a readability score where 12 equals newspaper and 18+ suggests obfuscation — is also unavailable. The absence of these metrics means the filing cannot be assessed by these established quantitative measures of financial health, reporting quality, or textual clarity, leaving a gap in the typical forensic accounting toolkit.

Turning to specific disclosures, the Item 1A “Risk Factors” section explicitly states there have been no material changes from the risk factors previously disclosed in our 2025 Form 10-K. This observation suggests a stable risk profile as perceived by management within the reporting quarter, directing readers to the annual filing for the full context of potential business challenges. Furthermore, under “Purchases of Equity Securities by the Issuer,” the filing details an equity repurchase program initially approved by the Board of Directors on October 30, 2013. While the Board has subsequently increased the authorization for stock repurchases, the continued mention of a program originating over a decade prior is notable, indicating a long-standing and consistent capital allocation strategy.

This reading of the IQVIA 2026 10-Q offers a glimpse into the company’s reporting style and a few specific disclosures, but its thinness limits broader conclusions. The heavy reliance on references to the 2025 Form 10-K means that a full understanding of IQVIA’s financial position, operational results, and comprehensive risk factors requires consulting the annual report. Without the quantitative insights from the Beneish M-Score, Altman Z″, Piotroski F-Score, or Fog Index, this filing cannot inform a data-driven assessment of potential earnings manipulation, bankruptcy risk, fundamental strength, or textual complexity. It describes the filing, not the security’s mispricing.

SEC filings · last 12 months

Filing timeline

View all on EDGAR →
  • May 7, 2026
    8-K
    Material event (2026-05-07)No specific items found in 8-K.0
    Read →
  • May 5, 2026
    10-Q
    Quarterly report (2026-03-31)Period: 2026-03-310
    Read →
  • May 5, 2026
    8-K
    Material event (2026-05-05)### Item 2.02 Results of Operations and Financial Condition On May 5, 2026, IQVIA Holdings Inc . (the “Company”) issued a press release announcing its financial0
    Read →
  • Apr 23, 2026
    8-K
    Material event (2026-04-23)### Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0
    Read →
  • Feb 27, 2026
    DEF 14A
    Proxy statement (2026-04-23)0
    Read →
  • Feb 17, 2026
    10-K
    Annual report (2025-12-31)Period: 2025-12-310
    Read →
Member feature · Custom Q&A
Ask anything about IQV's filings.
Plain-English answer, cited from the company's own 10-K and recent 10-Qs. No buy/sell advice.
Ask a question →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →
Quality of Earnings

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →